Cumberland Pharmaceuticals (CPIX) Reports Q4 EPS of $0.17

Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q4 EPS of $0.17. Revenue for the quarter came in at $40 million.

For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.

You May Also Be Interested In

• Barrick Mining said to delay IPO of American gold business to 2027
• PVH Corp. (PVH) Tops Q2 EPS by 62c, Beats on Revenue; Offers FY27 EPS Guidance
• Methode Electronics (MEI) Tops Q1 EPS by 2c; offers guidance